These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 19181604)

  • 1. Plasma transforming growth factor-beta1 level in patients with severe community-acquired pneumonia and association with disease severity.
    Wu HP; Chen CK; Chung K; Jiang BY; Yu TJ; Chuang DY
    J Formos Med Assoc; 2009 Jan; 108(1):20-7. PubMed ID: 19181604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic cytokine levels in community-acquired pneumonia and their association with disease severity.
    Antunes G; Evans SA; Lordan JL; Frew AJ
    Eur Respir J; 2002 Oct; 20(4):990-5. PubMed ID: 12412694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of transforming growth factor-β1 and correlated elevation of interleukin-17 and interferon-γ in pediatric patients with chronic primary immune thrombocytopenia (ITP).
    Wang JD; Chang TK; Lin HK; Huang FL; Wang CJ; Lee HJ
    Pediatr Blood Cancer; 2011 Oct; 57(4):636-40. PubMed ID: 21721104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Transforming Growth Factor β1/Interleukin-31 Pathway Is Upregulated in Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure and Is Associated with Disease Severity and Survival.
    Yu X; Guo R; Ming D; Deng Y; Su M; Lin C; Li J; Lin Z; Su Z
    Clin Vaccine Immunol; 2015 May; 22(5):484-92. PubMed ID: 25716231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the Outcomes of Subjects With Severe Community-Acquired Pneumonia Using Monocyte Human Leukocyte Antigen-DR.
    Zhuang Y; Li W; Wang H; Peng H; Chen Y; Zhang X; Chen Y; Gao C
    Respir Care; 2015 Nov; 60(11):1635-42. PubMed ID: 26264418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine Concentrations in Plasma from Children with Severe and Non-Severe Community Acquired Pneumonia.
    Haugen J; Chandyo RK; Brokstad KA; Mathisen M; Ulak M; Basnet S; Valentiner-Branth P; Strand TA
    PLoS One; 2015; 10(9):e0138978. PubMed ID: 26407163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local and systemic cytokine profiles in nonsevere and severe community-acquired pneumonia.
    Paats MS; Bergen IM; Hanselaar WE; Groeninx van Zoelen EC; Hoogsteden HC; Hendriks RW; van der Eerden MM
    Eur Respir J; 2013 Jun; 41(6):1378-85. PubMed ID: 23258791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of plasma human β-defensin 2 level on short-term clinical outcomes in patients with community-acquired pneumonia: a preliminary study.
    Liu S; He LR; Wang W; Wang GH; He ZY
    Respir Care; 2013 Apr; 58(4):655-61. PubMed ID: 23051183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis.
    Hedlund J
    Scand J Infect Dis Suppl; 1995; 97():1-60. PubMed ID: 8584866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of serum pregnancy-associated plasma protein A level at the initial ED presentation in elderly patients with CAP.
    Golcuk Y; Golcuk B; Bilge A; Korkmaz A; Irik M; Hayran M; Ozdemir AT; Kurtulmus Y
    Am J Emerg Med; 2015 Sep; 33(9):1232-6. PubMed ID: 26113245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia.
    Rello J; Rodriguez A; Lisboa T; Gallego M; Lujan M; Wunderink R
    Crit Care Med; 2009 Feb; 37(2):456-62. PubMed ID: 19114916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma kallistatin levels in patients with severe community-acquired pneumonia.
    Lin WC; Lu SL; Lin CF; Chen CW; Chao L; Chao J; Lin YS
    Crit Care; 2013 Feb; 17(1):R27. PubMed ID: 23394256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality prediction in community-acquired pneumonia requiring mechanical ventilation; values of pneumonia and intensive care unit severity scores.
    Aydoğdu M; Ozyilmaz E; Aksoy H; Gürsel G; Ekim N
    Tuberk Toraks; 2010; 58(1):25-34. PubMed ID: 20517726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic and stratified value of adrenomedullin in community acquired pneumonia patients in emergency department].
    Chen Y; Li C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Feb; 26(2):115-9. PubMed ID: 24524403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and bronchoalveolar cytokines as predictors of in-hospital mortality in severe community-acquired pneumonia.
    Lee YL; Chen W; Chen LY; Chen CH; Lin YC; Liang SJ; Shih CM
    J Crit Care; 2010 Mar; 25(1):176.e7-13. PubMed ID: 19592208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma d-dimer levels correlate with outcomes in patients with community-acquired pneumonia.
    Querol-Ribelles JM; Tenias JM; Grau E; Querol-Borras JM; Climent JL; Gomez E; Martinez I
    Chest; 2004 Oct; 126(4):1087-92. PubMed ID: 15486368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated TGF-β1/IL-31 Pathway Is Associated with the Disease Severity of Hepatitis B Virus-Related Liver Cirrhosis.
    Ming D; Yu X; Guo R; Deng Y; Li J; Lin C; Su M; Lin Z; Su Z
    Viral Immunol; 2015 May; 28(4):209-16. PubMed ID: 25710085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of coagulation parameters on the outcomes of patients with severe community-acquired pneumonia requiring intensive care unit admission.
    Salluh JIF; Rabello LSCF; Rosolem MM; Soares M; Bozza FA; Verdeal JCR; Mello GW; Castro Faria Neto HC; Lapa E Silva JR; Bozza PT
    J Crit Care; 2011 Oct; 26(5):496-501. PubMed ID: 21454038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β Blood Levels Distinguish Between Influenza A (H1N1)pdm09 Virus Sepsis and Sepsis due to Other Forms of Community-Acquired Pneumonia.
    Rendón-Ramirez EJ; Ortiz-Stern A; Martinez-Mejia C; Salinas-Carmona MC; Rendon A; Mata-Tijerina VL; Rosas-Taraco AG
    Viral Immunol; 2015 Jun; 28(5):248-54. PubMed ID: 25923384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CURB-65, PSI, and APACHE II to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS.
    Richards G; Levy H; Laterre PF; Feldman C; Woodward B; Bates BM; Qualy RL
    J Intensive Care Med; 2011; 26(1):34-40. PubMed ID: 21341394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.